Linked Life Data

21679984

Source:http://linkedlifedata.com/resource/pubmed/id/21679984

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2011-7-11
pubmed:abstractText
Definitions of prostate cancer risk are limited since accurate attribution of the cancer grade and burden is not possible due to the random and systematic errors associated with transrectal ultrasound guided biopsy. Transperineal prostate mapping biopsy may have a role in accurate risk stratification. We defined the transperineal prostate mapping biopsy characteristics of clinically significant disease.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1527-3792
pubmed:author
pubmed:copyrightInfo
Copyright © 2011 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
186
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
458-64
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Characterizing clinically significant prostate cancer using template prostate mapping biopsy.
pubmed:affiliation
Division of Surgery and Interventional Science, Centre for Medical Imaging Computing, University College London, Department of Histopathology, University College London Hospitals National Health Service Foundation Trust, London, United Kingdom. hashim.ahmed@ucl.ac.uk
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't